+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Does growth hormone therapy induce IgA nephropathy?

Does growth hormone therapy induce IgA nephropathy?

Pediatric Nephrology 20(12): 1821-1822

We report the cases of two patients who developed acute renal failure following multiple wasp stings. Both patients required dialysis and recovered within 4 weeks. The kidney biopsy from one patient showed acute tubular necrosis with interstitial nephritis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 011973928

Download citation: RISBibTeXText

PMID: 16222552

DOI: 10.1007/s00467-005-2037-z

Related references

Pulsatile growth hormone releasing hormone treatment can induce growth hormone and somatomedin c responses in growth hormone deficient children initially unresponsive to single bolus growth hormone releasing hormone. Pediatric Research 20(4 Part 2): 217A, 1986

Repeated stimulation with growth hormone releasing hormone can induce a growth hormone response in initially unresponsive growth hormone deficient patients. Journal of Pediatric Endocrinology 4(1): 1-6, 1991

Growth hormone therapy does not induce catch up growth in small for gestational age sga rats. Pediatric Research 25(4 Part 2): 93A, 1989

Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardation. Hormone Research in Paediatrics 75(2): 106-114, 2011

Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone. Journal of Endocrinological Investigation 15(10): 735-739, 1992

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. Journal of Clinical Endocrinology and Metabolism 81(3): 1189-1196, 1996

Growth hormone therapy in boy with panhypopituitarism may induce pilomatricoma recurrence: case report. Neuro Endocrinology Letters 29(1): 51-54, 2008

Glucose tolerance in non-growth hormone deficient adolescents treated with long-term growth hormone therapy on and off growth hormone therapy. Hormone Research (Basel) 50(Suppl. 3): 57, 1998

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Journal of Clinical Endocrinology & Metabolism 81(3): 1189-1196, 1996

Analogs of growth hormone-releasing hormone induce release of growth hormone in the bovine. Journal of Animal Science 66(6): 1386-1392, 1988

Clinical Notes on Fatty Tumours of the Larynx. Transactions. Medico-Chirurgical Society of Edinburgh 8: 43-47, 1889

Growth hormone responses to growth hormone releasing hormone in type 1 insulin dependent diabetic patients with incipient diabetic nephropathy. Diabetologia 31(7): 531A, 1988

Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy. Journal of Pediatrics 104(6): 908-911, 1984

Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Clinical Endocrinology 42(4): 365-372, 1995

Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone. Endocrine 15(1): 51-56, 2001